Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Contemp Clin Trials. 2015 Feb 3;41:192–201. doi: 10.1016/j.cct.2015.01.018

Table 3. Medication Types used by Randomized Patients (N=305).

Variable TOTAL UC PASM



N=305 % N=156 % N=149 %
Mean(SD) Number of Medications 11.47 5.51 11.42 5.42 11.51 5.63
Beta-agonist 158 51.80 76 48.72 82 55.03
Anti-cholinergic 178 58.36 91 48.33 87 58.39
Inhaled Corticosteroid 44 14.43 21 13.46 23 15.44
Long Acting Beta Agonist/Corticosteroid combination 142 46.56 78 50.00 64 42.95
Nebulizer 117 38.36 57 36.54 60 40.27
Systemic bronchodilator 18 5.90 9 5.77 9 6.04
Oral corticosteroid 49 16.07 28 17.95 21 14.09
Antibiotic 46 15.08 24 15.38 22 14.77
Anti-tussive/mucolytic 35 11.48 20 12.82 15 10.07
Cardiac/Antihypertensive 260 85.25 134 85.90 126 84.56
Diuretic 113 37.05 57 36.54 56 37.58
Endocrinologic 102 33.44 48 30.77 54 36.24
Allergy 142 46.56 75 48.08 67 44.97
Gastrointestinal 133 43.61 64 41.03 69 46.31
Electrolytes/vitamins/minerals 189 61.97 100 64.10 89 59.73
Gout 7 2.30 6 3.85 1 0.67
Opthamologic 20 6.56 9 5.77 11 7.38
Neurologic 55 18.03 24 15.38 31 20.81
Psychiatric 123 40.33 66 42.31 57 38.26
Urologic 45 14.75 25 16.03 20 13.42
Analgesic 158 51.80 86 55.13 72 48.32
Antiviral 3 0.98 1 0.64 2 1.34
Complementary/Alternative 21 6.89 10 6.41 11 7.38
Oxygen 122 40.00 67 42.95 55 36.91
Osteoporosis 25 8.20 14 8.97 11 7.38
Antienetic 4 1.31 2 1.28 2 1.34
Oncology/Immunosuppressive/anti-inflammatory 11 3.61 5 3.21 6 4.03
Smoking cessation 5 1.64 2 1.28 3 2.01
Topical Steroid/Dermatologic 14 4.59 11 7.05 3 2.01
Alpha 1 Antitrypsin 2 0.66 1 0.64 1 0.67

UC-Usual Care; PASM-Physical Activity Self-Management; SD- Standard deviation